Verzenio (abemaciclib) - Eli Lilly
Abemaciclib in Patients With Oligodendroglioma (clinicaltrials.gov) - Sep 26, 2026 - P2 | N=10 | Completed | Sponsor: Stephen Bagley, MD, MSCE | Active, not recruiting ➔ Completed | Trial completion date: May 2027 ➔ Feb 2026 
Trial completion • Trial completion date • Brain Cancer • Glioma • Oligodendroglioma • Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT03969706
 
Sep 26, 2026
 
Prev Next